{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:12:56Z","timestamp":1788606776000,"version":"build-2803163510"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Nanjing Health Science and Technology Development Special Fund Project","award":["ZKX23033"],"award-info":[{"award-number":["ZKX23033"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Atherosclerosis (AS), a chronic inflammatory disease driven by lipid accumulation and immune dysregulation, predisposes to acute cardiovascular events via plaque rupture and thrombosis. The molecular mechanisms linking immune microenvironment imbalance to plaque instability remain incompletely defined. Utilizing the GSE100927 dataset (69 AS patients vs 35 controls), we identified differentially expressed genes (DEGs) and constructed co-expression networks via weighted gene co-expression network analysis. Hub genes were intersected with DEGs to determine core genes. Immune cell infiltration was quantified using Cell-type Identification By Estimating Relative Subsets Of RNA Transcripts, and correlations between core genes and immune subsets were assessed. Diagnostic potential was evaluated by receiver operating characteristic (ROC) analysis. We identified 2596 DEGs (1575 up-\/1021 downregulated) in AS tissues. Weighted gene co-expression network analysis revealed 3 disease-associated modules, yielding 54 hub genes. Intersection with DEGs identified 12 core genes, including HLA-G, HLA-A, HLA-C, and beta-2-microglobulin (B2M). These genes were enriched in \u201cmajor histocompatibility complex class Ib-mediated antigen presentation\u201d and significantly upregulated in AS (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). Immune profiling showed elevated M0 macrophages and reduced resting CD4\n                      <jats:sup>+<\/jats:sup>\n                      memory T cells in AS (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.0001). Expression of HLA-G, HLA-A, HLA-C, and B2M positively correlated with M0 macrophages and negatively with CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). ROC analysis within the GSE100927 dataset demonstrated high diagnostic accuracy for distinguishing AS samples from controls (HLA-G\/A\/C area under the ROC curve\u2005=\u20050.94; B2M area under the ROC curve\u2005=\u20050.87). HLA-G, HLA-A, HLA-C, and B2M modulate macrophage and T cell functions, driving immune dysregulation in AS. This immune imbalance is associated with plaque instability and may contribute to thrombosis risk, highlighting the potential of these molecules as diagnostic biomarkers and therapeutic targets.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050480","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:00:15Z","timestamp":1788606015000},"page":"e50480","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Immunomodulatory roles of the HLA family and B2M in atherosclerosis"],"prefix":"10.1097","volume":"105","author":[{"given":"Ke","family":"Ma","sequence":"first","affiliation":[{"name":"Women\u2019s Hospital of Nanjing Medical University (Nanjing Women and Children\u2019s Healthcare Hospital), Nanjing, Jiangsu, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7036-7284","authenticated-orcid":false,"given":"Jingping","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260905","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis.","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20260905","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","article-title":"Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease.","volume":"118","author":"Herrington","year":"2016","journal-title":"Circ Res"},{"key":"R3-20260905","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/pin.13202","article-title":"Atherosclerosis: known and unknown.","volume":"72","author":"Fan","year":"2022","journal-title":"Pathol Int"},{"key":"R4-20260905","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption.","volume":"92","author":"Falk","year":"1995","journal-title":"Circulation"},{"key":"R5-20260905","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis.","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R6-20260905","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/hq1201.100220","article-title":"Immune mechanisms in atherosclerosis.","volume":"21","author":"Hansson","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R7-20260905","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease.","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"R8-20260905","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11883-001-0067-y","article-title":"The role of chemokines in atherosclerosis.","volume":"3","author":"Mach","year":"2001","journal-title":"Curr Atheroscler Rep"},{"issue":"Suppl","key":"R9-20260905","doi-asserted-by":"crossref","first-page":"S364","DOI":"10.1194\/jlr.R800092-JLR200","article-title":"The role of adaptive T cell immunity in atherosclerosis.","volume":"50","author":"Mallat","year":"2009","journal-title":"J Lipid Res"},{"key":"R10-20260905","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis.","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"R11-20260905","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles.","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"R12-20260905","doi-asserted-by":"crossref","first-page":"1079185","DOI":"10.3389\/fphar.2022.1079185","article-title":"Advances in immunotherapy modalities for atherosclerosis.","volume":"13","author":"Meng","year":"2022","journal-title":"Front Pharmacol"},{"key":"R13-20260905","doi-asserted-by":"crossref","first-page":"1437821","DOI":"10.3389\/fimmu.2024.1437821","article-title":"Immunological perspectives on atherosclerotic plaque formation and progression.","volume":"15","author":"Pi","year":"2024","journal-title":"Front Immunol"},{"key":"R14-20260905","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis.","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"R15-20260905","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","article-title":"Immune and inflammatory mechanisms of atherosclerosis.","volume":"27","author":"Galkina","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"R16-20260905","doi-asserted-by":"crossref","first-page":"5245308","DOI":"10.1155\/2020\/5245308","article-title":"Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis.","volume":"2020","author":"Khatana","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"R17-20260905","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0065-2776(03)81006-4","article-title":"HLA-G molecules: from maternal-fetal tolerance to tissue acceptance.","volume":"81","author":"Carosella","year":"2003","journal-title":"Adv Immunol"},{"key":"R18-20260905","first-page":"1141","article-title":"Association between two polymorphisms in the HLA-G gene and angiographic coronary artery disease.","volume":"5","author":"Boiocchi","year":"2012","journal-title":"Mol Med Rep"},{"key":"R19-20260905","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/iji.12513","article-title":"HLA-G: function, polymorphisms and pathology.","volume":"48","author":"Arnaiz-Villena","year":"2021","journal-title":"Int J Immunogenet"},{"key":"R20-20260905","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2021.06.008","article-title":"Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy.","volume":"517","author":"Wang","year":"2021","journal-title":"Cancer Lett"},{"key":"R21-20260905","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-immunol-032712-095954","article-title":"Memory T cell subsets, migration patterns, and tissue residence.","volume":"31","author":"Mueller","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"R22-20260905","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice.","volume":"54","author":"Libby","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R23-20260905","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2147\/VHRM.S37119","article-title":"Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.","volume":"9","author":"Kones","year":"2013","journal-title":"Vasc Health Risk Manag"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:00:18Z","timestamp":1788606018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050480"}},"subtitle":["Diagnostic biomarkers and thrombosis risk"],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":23,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050480","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"2025-08-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}